Association of early hypotension in pediatric sepsis with development of new or persistent acute kidney injury.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
02 2021
Historique:
received: 11 02 2020
accepted: 30 06 2020
revised: 17 06 2020
pubmed: 28 7 2020
medline: 24 12 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

To determine how hypotension in the first 48 h of sepsis management impacts acute kidney injury (AKI) development and persistence. Retrospective study of patients > 1 month to < 20 years old with sepsis in a pediatric ICU between November 2012 and January 2015 (n = 217). All systolic blood pressure (SBP) data documented within 48 h after sepsis recognition were collected and converted to percentiles for age, sex, and height. Time below SBP percentiles and below pediatric advanced life support (PALS) targets was calculated by summing elapsed time under SBP thresholds during the first 48 h. The primary outcome was new or persistent AKI, defined as stage 2 or 3 AKI present between sepsis day 3-7 using Kidney Disease: Improving Global Outcomes creatinine definitions. Secondary outcomes included AKI-free days (days alive and free of AKI) and time to kidney recovery. Fifty of 217 sepsis patients (23%) had new or persistent AKI. Patients with AKI spent a median of 35 min under the first SBP percentile, versus 4 min in those without AKI. After adjustment for potential confounders, the odds of AKI increased by 9% with each doubling of minutes spent under this threshold (p = 0.03). Time under the first SBP percentile was also associated with fewer AKI-free days (p = 0.02). Time spent under PALS targets was not associated with AKI. The duration of severe systolic hypotension in the first 48 h of pediatric sepsis management is associated with AKI incidence and duration when defined by age, sex, and height norms, but not by PALS definitions. Graphical abstract.

Identifiants

pubmed: 32710239
doi: 10.1007/s00467-020-04704-2
pii: 10.1007/s00467-020-04704-2
pmc: PMC7856266
mid: NIHMS1641991
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-461

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD082368
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK119463
Pays : United States
Organisme : NICHD NIH HHS
ID : R43 HD096961
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107566
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK104730
Pays : United States
Organisme : NIGMS NIH HHS
ID : K23 GM110496
Pays : United States

Références

N Engl J Med. 2001 Nov 8;345(19):1368-77
pubmed: 11794169
Crit Care Med. 2014 Nov;42(11):2409-17
pubmed: 25148597
Intensive Care Med. 2008 Jun;34(6):1065-75
pubmed: 18369591
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
N Engl J Med. 2017 Jan 5;376(1):11-20
pubmed: 27959707
Pediatr Crit Care Med. 2017 Aug;18(8):750-757
pubmed: 28486385
Crit Care Med. 2018 Jul;46(7):e677-e683
pubmed: 29677008
Intensive Care Med. 2003 Feb;29(2):278-85
pubmed: 12541154
Kidney Int Suppl (2011). 2012 Mar;2(1):19-36
pubmed: 25018918
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
Crit Care Med. 2016 Dec;44(12):2241-2250
pubmed: 27513354
Circulation. 2010 Nov 2;122(18 Suppl 3):S876-908
pubmed: 20956230
Pediatr Crit Care Med. 2012 Jul;13(4):e219-26
pubmed: 22460773
Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57
pubmed: 25734408
Crit Care. 2008;12(2):R47
pubmed: 18402655
Pediatrics. 2001 Jun;107(6):E99
pubmed: 11389297
JAMA. 2020 Mar 10;323(10):938-949
pubmed: 32049269
Pediatr Crit Care Med. 2015 Oct;16(8):703-10
pubmed: 26132741
Pediatr Crit Care Med. 2012 Sep;13(5):501-8
pubmed: 22460772
Pediatr Crit Care Med. 2016 Sep;17(9):817-22
pubmed: 27455114
Crit Care Med. 2014 Jun;42(6):1518-23
pubmed: 24561563
Pediatr Crit Care Med. 2017 Aug;18(8):733-740
pubmed: 28492401
Intensive Care Med. 2018 Mar;44(3):384-386
pubmed: 29242969
Intensive Care Med. 2015 Sep;41(9):1648-57
pubmed: 26156107
Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106
pubmed: 32032273
Clin J Am Soc Nephrol. 2008 Jul;3(4):948-54
pubmed: 18417742
Intensive Care Med. 2017 Mar;43(3):433-435
pubmed: 27990596
Crit Care. 2013 Dec 13;17(6):R295
pubmed: 24330815
Pediatr Nephrol. 2018 Oct;33(10):1781-1790
pubmed: 29948309
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356
Crit Care Med. 2017 Jun;45(6):1061-1093
pubmed: 28509730
Shock. 2017 Jul;48(1):29-35
pubmed: 28114166

Auteurs

Julie C Fitzgerald (JC)

Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA. fitzgeraldj@email.chop.edu.
Department of Anesthesiology, Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Blvd., 6th Floor Wood Building, Room 6117, Philadelphia, PA, 19104, USA. fitzgeraldj@email.chop.edu.

Michelle E Ross (ME)

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Neal J Thomas (NJ)

Department of Pediatrics, Penn State Hershey Children's Hospital, Penn State University College of Medicine, Hershey, PA, USA.

Scott L Weiss (SL)

Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Anesthesiology, Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Blvd., 6th Floor Wood Building, Room 6117, Philadelphia, PA, 19104, USA.

Fran Balamuth (F)

Department of Pediatrics, Division of Emergency Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marianne Chilutti (M)

Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Robert W Grundmeier (RW)

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Amanda Hyre Anderson (AH)

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH